X0206 3 2013-03-20 0 0001177648 ENANTA PHARMACEUTICALS INC ENTA 0001133921 SCHUHSLER HELMUT C/O TVM CAPITAL GROUP MAXIMILIANSTRASSE 35 C MUNICH 2M 80539 GERMANY 1 0 1 0 Series C Convertible Preferred Stock Common Stock 236065 I See footnote Series D Convertible Preferred Stock Common Stock 351014 I See footnote Series D Convertible Preferred Stock Common Stock 155316 I See footnote Series E Convertible Preferred Stock Common Stock 172030 I See footnote Series E Convertible Preferred Stock Common Stock 1006498 I See footnote Series G-2 Convertible Preferred Stock Common Stock 478247 I See footnote Warrants .01 2017-10-04 Series 1 Non-Convertible Preferred Stock 544888 I See footnote The shares have no expiration date and are convertible into Enanta Pharmaceuticals, Inc. ("Enanta") Common Stock on a 0.23202-for-one basis and will automatically convert upon the closing of the initial public offering of Enanta without payment of further consideration. The shares have no expiration date and are convertible into Enanta Common Stock on a 0.31063-for-one basis and will automatically convert upon the closing of the initial public offering of Enanta without payment of further consideration. The shares have no expiration date and are convertible into Enanta Common Stock on a 0.30529-for-one basis and will automatically convert upon the closing of the initial public offering of Enanta without payment of further consideration. The shares have no expiration date and are convertible into Enanta Common Stock on a 0.23202-for-one basis and will automatically convert upon the closing of the initial public offering of Enanta without payment of further consideration. These warrants are immediately exercisable. The shares are directly held by TVM Medical Ventures GmbH & Co. KG ("Medical Ventures"), the general partner of which is TVM Capital GmbH ("TVM Capital"), for which Helmut Schuhsler ("Schuhsler"), one member of the investment committee of TVM Capital, shares voting and investment authority over the shares held by Medical Ventures with the other member of the investment committee. Schuhsler disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. The shares are directly held by TVM IV GmbH & Co. KG ("TVM IV"), the managing limited partner of which is TVM IV Management GmbH & Co. KG ("TVM IV Management"), for which Schuhsler, one member of the investment committee of TVM IV Management, shares voting and investment authority over the shares held by TVM IV with the other members of the investment committee. Schuhsler disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. The shares are directly held by TVM V Life Science Ventures GmbH & Co. KG ("TVM V"), the managing limited partner of which is TVM V Life Science Ventures Management GmbH & Co. KG ("TVM V Management"), for which for which Schuhsler, one member of the investment committee of TVM V Management, shares voting and investment authority over the shares held by TVM V with the other members of the investment committee. Schuhsler disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. /s/ Rolf Starck by power of attorney for Helmut Schuhsler 2013-03-20